替比夫定阻断HBV DNA高载量孕妇母婴传播的疗效和安全性观察
目的评价妊娠早期（12周）应用替比夫定阻断高病毒载量孕妇母婴传播的疗效和安全性。方法选择妊娠12周慢性乙型肝炎孕妇80例,病毒载量均超过1×10^7拷贝/ml。按患者意愿分治疗组（替比夫定组）38例和对照组42例,治疗组口服替比夫定600 mg,1次/d,加用复方甘草酸苷保肝治疗,替比夫定服用至产后12周;对照组不给予抗病毒药物,只给予复方甘草酸苷保肝治疗。两组新生儿出生后均接种乙型肝炎免疫球蛋白200 IU与乙型肝炎疫苗20μg。婴儿7月龄时HBsAg及HBV DNA阳性者为HBV宫内感染。观察两组患者母体HBV DNA水平的变化情况和新生儿HBsAg的阳性率。对两组HBsAg阳性率的差异分...
Saved in:
| Published in | 临床肝胆病杂志 Vol. 29; no. 8; pp. 596 - 599 |
|---|---|
| Main Author | |
| Format | Journal Article |
| Language | Chinese |
| Published |
中国海洋大学医药学院,山东青岛266021
2013
青岛市城阳人民医院感染科,山东青岛,266021%青岛市市立医院消化内二科,山东青岛266021 青岛市消化疾病重点实验室,山东青岛266021%青岛市市立医院消化内二科,山东青岛266021 青岛市消化疾病重点实验室,山东青岛266021 |
| Subjects | |
| Online Access | Get full text |
| ISSN | 1001-5256 |
| DOI | 10.3969/j.issn.1001-5256.2013.08.011 |
Cover
| Abstract | 目的评价妊娠早期（12周）应用替比夫定阻断高病毒载量孕妇母婴传播的疗效和安全性。方法选择妊娠12周慢性乙型肝炎孕妇80例,病毒载量均超过1×10^7拷贝/ml。按患者意愿分治疗组（替比夫定组）38例和对照组42例,治疗组口服替比夫定600 mg,1次/d,加用复方甘草酸苷保肝治疗,替比夫定服用至产后12周;对照组不给予抗病毒药物,只给予复方甘草酸苷保肝治疗。两组新生儿出生后均接种乙型肝炎免疫球蛋白200 IU与乙型肝炎疫苗20μg。婴儿7月龄时HBsAg及HBV DNA阳性者为HBV宫内感染。观察两组患者母体HBV DNA水平的变化情况和新生儿HBsAg的阳性率。对两组HBsAg阳性率的差异分析采用卡方检验;组间比较行t（t＇）检验,治疗前后的比较采用配对t检验。结果至分娩前,替比夫定组孕妇HBV DNA、ALT水平明显下降。替比夫定组HBV DNA载量于治疗2周后迅速下降,之后缓慢下降直至分娩。替比夫定组服药至分娩前及分娩后12周HBVDNA水平明显降低（t=29.15、40.06,P〈0.01）,而对照组无明显变化（P〉0.05）。替比夫定组分娩前及分娩后12周HBV DNA水平较对照组明显下降（P〈0.01）。替比夫定组新生儿7月龄时HBV感染率为0,明显低于对照组14.3%,差异有统计学意义（χ2=3.99,P〈0.05）,替比夫定组母婴均无不良事件发生,对照组有2例发生严重肝功能异常。两组孕产妇的剖宫产率、不良妊娠率、产后出血率及新生儿的胎龄、体质量、身长、Apgar评分等,差异均无统计学意义。结论乙型肝炎病毒高载量孕妇孕12周开始应用替比夫定可显著抑制孕妇外周血清HBV DNA水平,降低新生儿HBV感染率,并具有良好的耐受性及安全性。 |
|---|---|
| AbstractList | 目的评价妊娠早期（12周）应用替比夫定阻断高病毒载量孕妇母婴传播的疗效和安全性。方法选择妊娠12周慢性乙型肝炎孕妇80例,病毒载量均超过1×10^7拷贝/ml。按患者意愿分治疗组（替比夫定组）38例和对照组42例,治疗组口服替比夫定600 mg,1次/d,加用复方甘草酸苷保肝治疗,替比夫定服用至产后12周;对照组不给予抗病毒药物,只给予复方甘草酸苷保肝治疗。两组新生儿出生后均接种乙型肝炎免疫球蛋白200 IU与乙型肝炎疫苗20μg。婴儿7月龄时HBsAg及HBV DNA阳性者为HBV宫内感染。观察两组患者母体HBV DNA水平的变化情况和新生儿HBsAg的阳性率。对两组HBsAg阳性率的差异分析采用卡方检验;组间比较行t（t＇）检验,治疗前后的比较采用配对t检验。结果至分娩前,替比夫定组孕妇HBV DNA、ALT水平明显下降。替比夫定组HBV DNA载量于治疗2周后迅速下降,之后缓慢下降直至分娩。替比夫定组服药至分娩前及分娩后12周HBVDNA水平明显降低（t=29.15、40.06,P〈0.01）,而对照组无明显变化（P〉0.05）。替比夫定组分娩前及分娩后12周HBV DNA水平较对照组明显下降（P〈0.01）。替比夫定组新生儿7月龄时HBV感染率为0,明显低于对照组14.3%,差异有统计学意义（χ2=3.99,P〈0.05）,替比夫定组母婴均无不良事件发生,对照组有2例发生严重肝功能异常。两组孕产妇的剖宫产率、不良妊娠率、产后出血率及新生儿的胎龄、体质量、身长、Apgar评分等,差异均无统计学意义。结论乙型肝炎病毒高载量孕妇孕12周开始应用替比夫定可显著抑制孕妇外周血清HBV DNA水平,降低新生儿HBV感染率,并具有良好的耐受性及安全性。 R512.62; 目的 评价妊娠早期(12周)应用替比夫定阻断高病毒载量孕妇母婴传播的疗效和安全性.方法 选择妊娠12周慢性乙型肝炎孕妇80例,病毒载量均超过1×107拷贝/ml.按患者意愿分治疗组(替比夫定组)38例和对照组42例,治疗组口服替比夫定600 mg,1次/d,加用复方甘草酸苷保肝治疗,替比夫定服用至产后12周；对照组不给予抗病毒药物,只给予复方甘草酸苷保肝治疗.两组新生儿出生后均接种乙型肝炎免疫球蛋白200 IU与乙型肝炎疫苗20μg.婴儿7月龄时HBsAg及HBV DNA阳性者为HBV宫内感染.观察两组患者母体HBV DNA水平的变化情况和新生儿HBsAg的阳性率.对两组HBsAg阳性率的差异分析采用卡方检验；组间比较行t(t')检验,治疗前后的比较采用配对t检验.结果 至分娩前,替比夫定组孕妇HBV DNA、ALT水平明显下降.替比夫定组HBV DNA载量于治疗2周后迅速下降,之后缓慢下降直至分娩.替比夫定组服药至分娩前及分娩后12周HBVDNA水平明显降低(t=29.15、40.06,P＜0.01),而对照组无明显变化(P＞0.05).替比夫定组分娩前及分娩后12周HBV DNA水平较对照组明显下降(P＜0.01).替比夫定组新生儿7月龄时HBV感染率为0,明显低于对照组14.3％,差异有统计学意义(x2=3.99,P＜O.05),替比夫定组母婴均无不良事件发生,对照组有2例发生严重肝功能异常.两组孕产妇的剖宫产率、不良妊娠率、产后出血率及新生儿的胎龄、体质量、身长、Apgar评分等,差异均无统计学意义.结论 乙型肝炎病毒高载量孕妇孕12周开始应用替比夫定可显著抑制孕妇外周血清HBV DNA水平,降低新生儿HBV感染率,并具有良好的耐受性及安全性. |
| Author | 孙维会 初蕾蕾 柳维林 郝岸华 马磊 万强 任蓉 辛永宁 |
| AuthorAffiliation | 青岛市城阳人民医院感染科,山东青岛266021 青岛市市立医院消化内二科,山东青岛266021 中国海洋大学医药学院,山东青岛266021 青岛市消化疾病重点实验室,山东青岛266021 |
| AuthorAffiliation_xml | – name: 青岛市城阳人民医院感染科,山东青岛,266021%青岛市市立医院消化内二科,山东青岛266021;青岛市消化疾病重点实验室,山东青岛266021%青岛市市立医院消化内二科,山东青岛266021;中国海洋大学医药学院,山东青岛266021;青岛市消化疾病重点实验室,山东青岛266021 |
| Author_xml | – sequence: 1 fullname: 孙维会 初蕾蕾 柳维林 郝岸华 马磊 万强 任蓉 辛永宁 |
| BookMark | eNo9kM9LAkEcxedgkJn_Q0GHLm4zOzvj7LHsh4HkRbrKzuysrdhaLhF5iigsKAJJEzvUIbIQ9dKtpH-mWfW_aMPo9B6PD-_L982BiFf2JABLCGrYpOZKUXN939MQhChBdEI1HSKsQaZBhCIg-p_PgrjvuxwShKlpEBoF2eDhKxjcqeeu6rcnrY-g2Uuv7S6s76xOuq3xcDip3apeQ73UgsGNenv__nwK6r1R-3zUvA8al6p-rfpX6uI1OO2MO2dq8DgPZhyr5Mv4n8ZAbnMjl0onMtmt7dRqJiGIiRKSYW5gzIgdGl0S2zQgMziH2BHSYdRAQiAHUw6hnuQCUcGllKZuYiRtYiRxDCxPa48tz7G8Qr5YPqp44cF8SRRsXq3-DgBZ-H6ILk5RsVf2CoduCB9U3H2rcpI3KGMI6wT_AGo0eT4 |
| ClassificationCodes | R512.62 |
| ContentType | Journal Article |
| Copyright | Copyright © Wanfang Data Co. Ltd. All Rights Reserved. |
| Copyright_xml | – notice: Copyright © Wanfang Data Co. Ltd. All Rights Reserved. |
| DBID | 2RA 92L CQIGP W91 ~WA 2B. 4A8 92I 93N PSX TCJ |
| DOI | 10.3969/j.issn.1001-5256.2013.08.011 |
| DatabaseName | 中文科技期刊数据库 中文科技期刊数据库-CALIS站点 中文科技期刊数据库-7.0平台 中文科技期刊数据库-医药卫生 中文科技期刊数据库- 镜像站点 Wanfang Data Journals - Hong Kong WANFANG Data Centre Wanfang Data Journals 万方数据期刊 - 香港版 China Online Journals (COJ) China Online Journals (COJ) |
| DatabaseTitleList | |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| DocumentTitleAlternate | Efficacy and safety of telbivudine in preventing mother-to-infant transmission of HBV in pregnant women with high HBV DNA load |
| DocumentTitle_FL | Efficacy and safety of telbivudine in preventing mother-to-infant transmission of HBV in pregnant women with high HBV DNA load |
| EndPage | 599 |
| ExternalDocumentID | lcgdbzz201308011 46881325 |
| GroupedDBID | -05 2B. 2C~ 2RA 5XA 5XF 92F 92I 92L ABDBF ACGFS ALMA_UNASSIGNED_HOLDINGS CCEZO CIEJG CQIGP CW9 EAD EAP EOJEC ESX GROUPED_DOAJ IPNFZ OBODZ OK1 RIG RNS TCJ TGQ U1G U5O W91 ~WA 4A8 93N ABJNI ACUHS PSX |
| ID | FETCH-LOGICAL-c591-e83b43385d83b2e5d94084bb03fcef8641cc1f36b0027bc16cbeee92931ed5473 |
| ISSN | 1001-5256 |
| IngestDate | Thu May 29 03:59:49 EDT 2025 Wed Feb 14 10:42:45 EST 2024 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 8 |
| Keywords | 替比夫定 hepatitis B virus disease transmission,vertical pregnancy 疾病传播,垂直 telbivudine 肝炎病毒,乙型 妊娠 |
| Language | Chinese |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c591-e83b43385d83b2e5d94084bb03fcef8641cc1f36b0027bc16cbeee92931ed5473 |
| Notes | hepatitis B virus; telbivudine; pregnancy; disease transmission; vertical Objective To evaluate the efficacy and safety of telbivudine given from the 12th week of gestation in preventing mother-to-infant transmission of hepatitis B virus（HBV） in pregnant women with high HBV DNA load.Methods Eighty pregnant women（at 12 weeks of gestation） with chronic hepatitis B,who had a HBV DNA load higher than 1.0×107 copies/ml,were enrolled.The patients were divided into two groups according to their personal preferences： treatment group（n=38） and control group（n=42）.The treatment group received oral telbivudine（600 mg） once daily until 12 weeks after delivery and was administered compound glycyrrhizin for liver protection,while the control group was given compound glycyrrhizin for liver protection alone.All infants in both groups were vaccinated with hepatitis B immunoglobulin（200 IU） and HBV vaccine（20 μg） after birth.The mother-to-infant transmission of HBV was indicated by the presence of HBsAg and HBV DNA in infants a |
| PageCount | 4 |
| ParticipantIDs | wanfang_journals_lcgdbzz201308011 chongqing_primary_46881325 |
| PublicationCentury | 2000 |
| PublicationDate | 2013 |
| PublicationDateYYYYMMDD | 2013-01-01 |
| PublicationDate_xml | – year: 2013 text: 2013 |
| PublicationDecade | 2010 |
| PublicationTitle | 临床肝胆病杂志 |
| PublicationTitleAlternate | Chinese Journal of Clinical Hepatology |
| PublicationTitle_FL | Journal of Clinical Hepatology |
| PublicationYear | 2013 |
| Publisher | 中国海洋大学医药学院,山东青岛266021 青岛市城阳人民医院感染科,山东青岛,266021%青岛市市立医院消化内二科,山东青岛266021 青岛市消化疾病重点实验室,山东青岛266021%青岛市市立医院消化内二科,山东青岛266021 青岛市消化疾病重点实验室,山东青岛266021 |
| Publisher_xml | – name: 中国海洋大学医药学院,山东青岛266021 – name: 青岛市消化疾病重点实验室,山东青岛266021%青岛市市立医院消化内二科,山东青岛266021 – name: 青岛市城阳人民医院感染科,山东青岛,266021%青岛市市立医院消化内二科,山东青岛266021 – name: 青岛市消化疾病重点实验室,山东青岛266021 |
| SSID | ssib051369456 ssj0041983 ssib001103858 ssib053243598 ssib002264326 ssib038074677 |
| Score | 1.9273211 |
| Snippet | 目的评价妊娠早期（12周）应用替比夫定阻断高病毒载量孕妇母婴传播的疗效和安全性。方法选择妊娠12周慢性乙型肝炎孕妇80例,病毒载量均超过1×10^7拷贝/ml。按患者意愿分治疗... R512.62; 目的 评价妊娠早期(12周)应用替比夫定阻断高病毒载量孕妇母婴传播的疗效和安全性.方法 选择妊娠12周慢性乙型肝炎孕妇80例,病毒载量均超过1×107拷贝/ml.按患者意... |
| SourceID | wanfang chongqing |
| SourceType | Aggregation Database Publisher |
| StartPage | 596 |
| SubjectTerms | 妊娠 替比夫定 疾病传播,垂直 肝炎病毒,乙型 |
| Title | 替比夫定阻断HBV DNA高载量孕妇母婴传播的疗效和安全性观察 |
| URI | http://lib.cqvip.com/qk/90100X/201308/46881325.html https://d.wanfangdata.com.cn/periodical/lcgdbzz201308011 |
| Volume | 29 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources issn: 1001-5256 databaseCode: M~E dateStart: 19850101 customDbUrl: isFulltext: true dateEnd: 99991231 titleUrlDefault: https://road.issn.org omitProxy: true ssIdentifier: ssib053243598 providerName: ISSN International Centre |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnR1Na9RANNQKxYv4ia0fVOicJDXJzCQzx8wmSxGslyq9LZuv9iBbP9rLHkREqYIiFFtLPehBrFLaXrxp8eYvMdv2X_jeJLvNFpEqhPCYefM-d3behHlvDGPMcRJuN21mNnkiTEZjakrhJqaT2KkLM4Rmka72OelO3GY3pvn0wLGflVNLC_PReNz-Y17J_3gV2sCvmCX7D57tEYUGgMG_8AYPw_tIPiahS6Qiqo6AXyeSkZATnxFfaSAk0iehJFIQpTQyoAUT6s61YFJ3AB70hdAd4AMtwiOirgcHRHINuNhYMBCBbpFEASdGVI34lqbrIH7oIT_BNACNehQQEQJHAY6olWIJiYAAWCCOsIjvoRjwFo7GAWX6ThxqdkLz5UQBFx_xAVkGGqBEuJqvh2SRb1CSAuvI3mLb1UwiLtikp4f0qyggcUEXpFdhDzhAAfp1omiFCrSEfYwkCiW1wZSDsiNdECqsfmgpMmT1pCg19PUI9GqARBWM1nYEHkJ13euVeoBvkGpNu1cgeb9e6ZKoqO_ANNJS2PgUXGRN9wbolUJAqSCIsoo88nKVwnNw3CkqsneXsfLDUTFdRWVN4tKthDe8uI_q8MpJpSv1yokMxnsM8Owj1TVuyyWxvzb53XgmidptRIKdB6bYH3c8iPjwCO2j8CAst62-mkmYvF3ZNuCdB6xSVpHb1JXsoMYTh6AfC012IyxmS1EkzpRSDhljpQrX_6YAlk-ZnWvN3IegUOfotbJma6YSTk6dMk6W-8BRv5jUp42B9uwZY-hmedLlrHGr8-5HZ_tN_nEj31rbX_3WWdmEeTsK83Z_Y3VvZ2d_8XW-uZx_Wuxsv8q_fP31_UNnaXN37enuytvO8vN86WW-9SJ_9rnzeH1v_Um-_f6cMVUPp2oTZnn5iRlzaZupoBGjYLUEACfliWSWYBEYK4vTTLjMjmM7oy5a04ti242jNE1hr0PtNMH7xM8bg625VnrBGGXSs6QTcQ-HRR6N0qbnZDKOmZdZjLJhY6Rnlsa9osZNg7lC2NThw8bV0k6N8o_vYeOw10eOgHPROOHoi2Tw4-UlY3D-wUJ6GcL5-eiK_q38BpOwvU8 |
| linkProvider | ISSN International Centre |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=%E6%9B%BF%E6%AF%94%E5%A4%AB%E5%AE%9A%E9%98%BB%E6%96%ADHBV+DNA%E9%AB%98%E8%BD%BD%E9%87%8F%E5%AD%95%E5%A6%87%E6%AF%8D%E5%A9%B4%E4%BC%A0%E6%92%AD%E7%9A%84%E7%96%97%E6%95%88%E5%92%8C%E5%AE%89%E5%85%A8%E6%80%A7%E8%A7%82%E5%AF%9F&rft.jtitle=%E4%B8%B4%E5%BA%8A%E8%82%9D%E8%83%86%E7%97%85%E6%9D%82%E5%BF%97&rft.au=%E5%AD%99%E7%BB%B4%E4%BC%9A&rft.au=%E5%88%9D%E8%95%BE%E8%95%BE&rft.au=%E6%9F%B3%E7%BB%B4%E6%9E%97&rft.au=%E9%83%9D%E5%B2%B8%E5%8D%8E&rft.date=2013&rft.pub=%E4%B8%AD%E5%9B%BD%E6%B5%B7%E6%B4%8B%E5%A4%A7%E5%AD%A6%E5%8C%BB%E8%8D%AF%E5%AD%A6%E9%99%A2%2C%E5%B1%B1%E4%B8%9C%E9%9D%92%E5%B2%9B266021&rft.issn=1001-5256&rft.volume=29&rft.issue=8&rft.spage=596&rft.epage=599&rft_id=info:doi/10.3969%2Fj.issn.1001-5256.2013.08.011&rft.externalDocID=lcgdbzz201308011 |
| thumbnail_s | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fimage.cqvip.com%2Fvip1000%2Fqk%2F90100X%2F90100X.jpg http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fwww.wanfangdata.com.cn%2Fimages%2FPeriodicalImages%2Flcgdbzz%2Flcgdbzz.jpg |